SCHEMBL14101569

SCHEMBL14101569

c1ccc2c(c1)sc1cc(-c3cc(-c4ccc5sc6ccccc6c5c4)c4ccc5c(-c6ccc7sc8ccccc8c7c6)cc(-c6ccc7sc8ccccc8c7c6)c6ccc3c4c65)ccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.47
ALDH1A1 P00352 3/20 0.47
RAB9A P51151 2/20 0.47
HPGD P15428 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
GPR3 P46089 1/20 0.47
TDP1 Q9NUW8 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
POLB P06746 1/20 0.41
ALOX5 P09917 1/20 0.41
CYP1A2 P05177 1/20 0.37
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
KDM4E B2RXH2 2/20 0.36
PTPN7 P35236 1/20 0.35
DUSP3 P51452 1/20 0.35
PTPN12 Q05209 1/20 0.35
PTPN22 Q9Y2R2 1/20 0.35
PIM3 Q86V86 1/20 0.35
PTGIR P43119 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14101568 0.92 GPR3 (0.45) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL14101439 0.86 F9 (0.40) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL14101482 0.86 MAPT (0.44) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL22373714 0.86 GPR3 (0.58) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL15315603 0.86 GPR3 (0.58) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL24171468 0.84 GPR3 (0.56) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL21036040 0.83 ALDH1A1 (0.47) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL21036067 0.83 GPR3 (0.47) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL13615864 0.82 GPR3 (0.54) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL17692118 0.82 NQO2 (0.40) MAPTALDH1A1RAB9AHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2008-07-10 US disclosed
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2008-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME CYBA, BPNT1, TYR MAPT 226/4885ALDH1A1 70/4885RAB9A 4235/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.